John A Rathmacher
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2019First federal award
$4.4MFederal grants as PI6 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
6 awards · $4.4M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 15, 2025 | NIH | STTR Phase II 2-HOBA for Treatment of Pulmonary Hypertension | $958K | MTI BIOTECH, INC. |
| Aug 30, 2024 | NIH | STTR Phase II 2-HOBA for Treatment of Pulmonary Hypertension | $958K | MTI BIOTECH, INC. |
| Aug 23, 2023 | NIH | STTR Phase II 2-HOBA for Treatment of Pulmonary Hypertension | $1.2M | MTI BIOTECH, INC. |
| Jul 26, 2021 | NIH | STTR Phase I 2-HOBA for Treatment of Pulmonary Hypertension | $257K | MTI BIOTECH, INC. |
| Apr 8, 2021 | NIH | STTR Phase I Efficacy of an Electrophile Scavenger in the Prevention of Gastrointestinal Inflammatory Carcinogenesis | $400K | MTI BIOTECH, INC. |
| Jul 8, 2019 | NIH | SBIR Phase II 2-Hydroxybenzylamine for the prevention of Alzheimer's disease: Initial evaluation in humans | $605K | MTI BIOTECH, INC. |
Peer ranks
Federal funding#340
Awards as PI#315
Patents#273
Companies
- MTI BIOTECH, INC.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.